Chronic fatigue syndrome

Steven F Reid; Trudie Chalder; Anthony Cleare; Matthew Hotopf; Simon Wessely

Chronic fatigue syndrome

Steven F Reid, Trudie Chalder, Anthony Cleare, Matthew Hotopf, Simon Wessely

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

Chronic fatigue syndrome (CFS) affects between 0.006% and 3% of the population depending on the criteria of definition used, with women being at higher risk than men. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for chronic fatigue syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2007 (BMJ Clinical evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Original language	English
Journal	BMJ Clinical Evidence
Volume	2008
Publication status	Published - 2008

Cite this

@article{59b7d99fb01443808af8daaa062467b1,

title = "Chronic fatigue syndrome",

abstract = "Chronic fatigue syndrome (CFS) affects between 0.006% and 3% of the population depending on the criteria of definition used, with women being at higher risk than men. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for chronic fatigue syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2007 (BMJ Clinical evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).",

author = "Reid, {Steven F} and Trudie Chalder and Anthony Cleare and Matthew Hotopf and Simon Wessely",

year = "2008",

language = "English",

volume = "2008",

journal = "BMJ Clinical Evidence",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Chronic fatigue syndrome

AU - Reid, Steven F

AU - Chalder, Trudie

AU - Cleare, Anthony

AU - Hotopf, Matthew

AU - Wessely, Simon

PY - 2008

Y1 - 2008

N2 - Chronic fatigue syndrome (CFS) affects between 0.006% and 3% of the population depending on the criteria of definition used, with women being at higher risk than men. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for chronic fatigue syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2007 (BMJ Clinical evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

AB - Chronic fatigue syndrome (CFS) affects between 0.006% and 3% of the population depending on the criteria of definition used, with women being at higher risk than men. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for chronic fatigue syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2007 (BMJ Clinical evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

M3 - Article

C2 - 19445810

VL - 2008

JO - BMJ Clinical Evidence

JF - BMJ Clinical Evidence

ER -

Chronic fatigue syndrome

Abstract

Fingerprint

Cite this